Cara Therapeutics (NASDAQ:CARA) Now Covered by StockNews.com
StockNews.com started coverage on shares of Cara Therapeutics (NASDAQ:CARA – Free Report) in a research report report published on Sunday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Cara Therapeutics Trading Down 3.0 % NASDAQ CARA opened at $4.80 on Friday. Cara Therapeutics has a 1-year low of $2.71 and a 1-year […]
StockNews.com started coverage on shares of Cara Therapeutics (NASDAQ:CARA – Free Report) in a research report report published on Sunday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Cara Therapeutics Trading Down 3.0 % NASDAQ CARA opened at $4.80 on Friday. Cara Therapeutics has a 1-year low of $2.71 and a 1-year […]